These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
354 related articles for article (PubMed ID: 22420924)
1. An immunohistochemical study of HER2 expression in meningioma and its correlation with tumor grade. Mahzouni P; Movahedipour M Pathol Res Pract; 2012 Apr; 208(4):221-4. PubMed ID: 22420924 [TBL] [Abstract][Full Text] [Related]
2. Recurrence of benign meningiomas: predictive value of proliferative index, BCL2, p53, hormonal receptors and HER2 expression. Abdelzaher E; El-Gendi SM; Yehya A; Gowil AG Br J Neurosurg; 2011 Dec; 25(6):707-13. PubMed ID: 20979437 [TBL] [Abstract][Full Text] [Related]
3. Osteopontin predicts the behaviour of atypical meningioma. Lin CK; Tsai WC; Lin YC; Hueng DY Histopathology; 2012 Jan; 60(2):320-5. PubMed ID: 22211290 [TBL] [Abstract][Full Text] [Related]
4. Correlation of p63 protein expression with histological grade of meningiomas: an immunohistochemical study. Mittal S; Jain D; Roy S; Mehta VS Int J Surg Pathol; 2012 Aug; 20(4):349-54. PubMed ID: 22287651 [TBL] [Abstract][Full Text] [Related]
5. [Expression of HER2/neu in meningiomas: an immunohistochemistry and fluorescence in situ hybridization study]. Wang CL; Mei JH; Wang SS; Xu S; Xu LL; Xiong YF Zhonghua Bing Li Xue Za Zhi; 2010 Mar; 39(3):156-60. PubMed ID: 20450760 [TBL] [Abstract][Full Text] [Related]
6. Expression of progestrone receptor and proliferative marker ki 67 in various grades of meningioma. Shayanfar N; Mashayekh M; Mohammadpour M Acta Med Iran; 2010; 48(3):142-7. PubMed ID: 21137648 [TBL] [Abstract][Full Text] [Related]
7. Prognostic value of HER2 expression in meningiomas: an immunohistochemical and fluorescence in situ hybridization study. Loussouarn D; Brunon J; Avet-Loiseau H; Campone M; Mosnier JF Hum Pathol; 2006 Apr; 37(4):415-21. PubMed ID: 16564915 [TBL] [Abstract][Full Text] [Related]
8. Association between laminin γ1 expression and meningioma grade, recurrence, and progression-free survival. Ke HL; Ke RH; Li B; Wang XH; Wang YN; Wang XQ Acta Neurochir (Wien); 2013 Jan; 155(1):165-71. PubMed ID: 23053286 [TBL] [Abstract][Full Text] [Related]
9. Improved correlation of the neuropathologic classification according to adapted world health organization classification and outcome after radiotherapy in patients with atypical and anaplastic meningiomas. Combs SE; Schulz-Ertner D; Debus J; von Deimling A; Hartmann C Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1415-21. PubMed ID: 20932661 [TBL] [Abstract][Full Text] [Related]
10. Correlation between histological grade, MIB-1, p53, and recurrence in 69 completely resected primary intracranial meningiomas with a 6 year mean follow-up. Lanzafame S; Torrisi A; Barbagallo G; Emmanuele C; Alberio N; Albanese V Pathol Res Pract; 2000; 196(7):483-8. PubMed ID: 10926326 [TBL] [Abstract][Full Text] [Related]
11. Immunocytochemical analysis of glucose transporter protein-1 (GLUT-1) in typical, brain invasive, atypical and anaplastic meningioma. van de Nes JA; Griewank KG; Schmid KW; Grabellus F Neuropathology; 2015 Feb; 35(1):24-36. PubMed ID: 25168354 [TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical expression of SPARC is correlated with recurrence, survival and malignant potential in meningiomas. Bozkurt SU; Ayan E; Bolukbasi F; Elmaci I; Pamir N; Sav A APMIS; 2009 Sep; 117(9):651-9. PubMed ID: 19703125 [TBL] [Abstract][Full Text] [Related]
13. Significance of COX-2 and VEGF expression in histopathologic grading and invasiveness of meningiomas. Lee SH; Lee YS; Hong YG; Kang CS APMIS; 2014 Jan; 122(1):16-24. PubMed ID: 23756256 [TBL] [Abstract][Full Text] [Related]
14. Correlation between histological grade and MIB-1 and p53 immunoreactivity in meningiomas. Ozen O; Demirhan B; Altinörs N Clin Neuropathol; 2005; 24(5):219-24. PubMed ID: 16167545 [TBL] [Abstract][Full Text] [Related]
15. Correlation of p63 immunoreactivity with tumor grade in meningiomas. Rushing EJ; Olsen C; Man YG Int J Surg Pathol; 2008 Jan; 16(1):38-42. PubMed ID: 18203782 [TBL] [Abstract][Full Text] [Related]
16. [Immunohistochemical expression of progesterone receptor in relationship with histological grade and risk of relapses in intracranial meningiomas]. Hernández Faraco A; Céspedes G; Trejo E Neurologia; 2009 May; 24(4):235-44. PubMed ID: 19603293 [TBL] [Abstract][Full Text] [Related]
17. Angiogenesis in intracranial meningiomas: immunohistochemical and molecular study. Pistolesi S; Boldrini L; Gisfredi S; De Ieso K; Camacci T; Caniglia M; Lupi G; Leocata P; Basolo F; Pingitore R; Parenti G; Fontanini G Neuropathol Appl Neurobiol; 2004 Apr; 30(2):118-25. PubMed ID: 15043709 [TBL] [Abstract][Full Text] [Related]
18. Does protein expression predict recurrence of benign World Health Organization grade I meningioma? Kärjä V; Sandell PJ; Kauppinen T; Alafuzoff I Hum Pathol; 2010 Feb; 41(2):199-207. PubMed ID: 19801161 [TBL] [Abstract][Full Text] [Related]
19. Expression of E-cadherin and catenins in meningioma: ubiquitous expression and its irrelevance to malignancy. Shimada S; Ishizawa K; Hirose T Pathol Int; 2005 Jan; 55(1):1-7. PubMed ID: 15660696 [TBL] [Abstract][Full Text] [Related]
20. Cell-adhesion molecules in human meningiomas: correlation with clinical and morphological data. Figarella-Branger D; Roche PH; Daniel L; Dufour H; Bianco N; Pellissier JF Neuropathol Appl Neurobiol; 1997 Apr; 23(2):113-22. PubMed ID: 9160896 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]